
Pfizer Covid-19 Vaccine Is on Track to Be Submitted for Regulatory Review in October
Pfizer COVID-19 vaccine created in cooperation with BioNTech SE is to be submitted for review in October. The duo will not accept any payments until they have successfully manufactured an effective vaccine.